PAH - Q&A - PACE-CME

Episodes 1-8 of 8

What is the underlying pathophysiology of PAH and what are its characteristics?
What is the underlying pathophysiology of PAH and what are its characteristics?
PAH - Q&A
What is the underlying pathophysiology of PAH and what are its characteristics?
- Nazzareno Galiè, MD
Which clinical PH groups can be distinguished?
Which clinical PH groups can be distinguished?
PAH - Q&A
Which clinical PH groups can be distinguished?
- Prof Nazzareno Galiè
How do we follow-up PAH patients non-responsive to therapy and how can therapy be optimized?
How do we follow-up PAH patients non-responsive to therapy and how can therapy be optimized?
PAH - Q&A
How do we follow-up PAH patients non-responsive to therapy and how can therapy be optimized?
- Nazzareno Galiè, MD
How common is PAH and what are its risk factors?
How common is PAH and what are its risk factors?
PAH - Q&A
How common is PAH and what are its risk factors?
- Prof Nazzareno Galiè
How is PAH diagnosed?
How is PAH diagnosed?
PAH - Q&A
How is PAH diagnosed?
- Prof Nazzareno Galiè
How can PAH patients be functionally classified
How can PAH patients be functionally classified
PAH - Q&A
How can PAH patients be functionally classified
- Nazzareno Galiè, MD
How is the prognosis of PAH established?
How is the prognosis of PAH established?
PAH - Q&A
How is the prognosis of PAH established?
- Nazzareno Galiè, MD
Which treatment options can be pursued and which drugs are approved for PAH?
Which treatment options can be pursued and which drugs are approved for PAH?
PAH - Q&A
Which treatment options can be pursued and which drugs are approved for PAH?
- Prof Nazzareno Galiè

Episodes 1-8 of 8

Title

Share on ReachMD